Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/why-experts-predict-binofi-bino-could-hit-2-after-exchange-listings-in-2025/